📰 David Cory News
Page 3 - David Cory News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Cory. Real-time updates on events, politics, business and more.
November 3, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
October 6, 2022
Eiger has announced that it will not seek EUA from the US FDA for peginterferon lambda to treat mild-to-moderate Covid-19 patients.
October 3, 2022
Bloodlands season 2 has seen the return of DCI Tom Brannick and the stakes couldnt be higher as he takes on his latest investigation...
September 6, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
August 7, 2022
Eiger BioPharmaceuticals, Inc. (NASDAQ:NASDAQ:EIGR) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Sarah Mathieson - SVP, Corporate Affairs David Cory -...
August 4, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
July 20, 2022
First and only treatment approved in Europe to treat Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies1Extende...
June 27, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...
June 7, 2022
Eiger nets approximately $11M after retiring its existing debt facilityImmediately bolsters cash position and provides access to an additional $35...
June 3, 2022
/PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies...